22ND CENTURY GROUP INC (XXII) Stock Price, Quote, News and Overview
NASDAQ:XXII - Nasdaq - US90137F4000 - Common Stock - Currency: USD
XXII Quote, Performance and Key Statistics
0.775
+0.02 (+2.27%)
The current stock price of XXII is 0.775 USD. In the past month the price decreased by -58.11%. In the past year, price decreased by -99.65%.
XXII Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| PM | PHILIP MORRIS INTERNATIONAL | 24.92 | 254.03B | ||
| MO | ALTRIA GROUP INC | 11.34 | 98.08B | ||
| BTI | BRITISH AMERICAN TOB-SP ADR | 8.79 | 93.01B | ||
| RLX | RLX TECHNOLOGY INC-ADR | 17.1 | 2.69B | ||
| UVV | UNIVERSAL CORP/VA | 9.99 | 1.28B | ||
| TPB | TURNING POINT BRANDS INC | 16.32 | 1.03B | ||
| ISPR | ISPIRE TECHNOLOGY INC | N/A | 167.84M |
Related stock screener links
About XXII
Company Profile
22nd Century Group, Inc. is a biotechnology company, which engages in the business of tobacco harm reduction, reduced nicotine tobacco, and improvement of health and wellness through plant science. The company is headquartered in Williamsville, New York and currently employs 64 full-time employees. The company went IPO on 2006-10-17. The firm is focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. Additionally, the Company provide contract manufacturing services for conventional combustible tobacco products for third-party brands. The firm operates through a single segment named Tobacco. Its tobacco segment is engaged in contract manufacturing organization (CMO) customer contracts that consist of obligations to manufacture the customers' branded filtered cigars and cigarettes. The tobacco segment is engaged in the sale of its reduced nicotine content (RNC) cigarettes, sold under the brand name VLN, or research cigarettes sold under the brand name SPECTRUM. The company uses plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the life science and consumer products.
Company Info
22ND CENTURY GROUP INC
8560 Main St Ste 4
Williamsville NEW YORK 14221 US
CEO: James A. Mish
Employees: 64
Company Website: https://www.xxiicentury.com/
Investor Relations: https://www.xxiicentury.com/investors
Phone: 17162701523
22ND CENTURY GROUP INC / XXII FAQ
What is the stock price of 22ND CENTURY GROUP INC today?
The current stock price of XXII is 0.775 USD. The price increased by 2.27% in the last trading session.
What is the ticker symbol for 22ND CENTURY GROUP INC stock?
The exchange symbol of 22ND CENTURY GROUP INC is XXII and it is listed on the Nasdaq exchange.
On which exchange is XXII stock listed?
XXII stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for 22ND CENTURY GROUP INC stock?
7 analysts have analysed XXII and the average price target is 13.26 USD. This implies a price increase of 1610.97% is expected in the next year compared to the current price of 0.775. Check the 22ND CENTURY GROUP INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is 22ND CENTURY GROUP INC worth?
22ND CENTURY GROUP INC (XXII) has a market capitalization of 1.84M USD. This makes XXII a Nano Cap stock.
How many employees does 22ND CENTURY GROUP INC have?
22ND CENTURY GROUP INC (XXII) currently has 64 employees.
Is 22ND CENTURY GROUP INC (XXII) expected to grow?
The Revenue of 22ND CENTURY GROUP INC (XXII) is expected to decline by -15% in the next year. Check the estimates tab for more information on the XXII EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy 22ND CENTURY GROUP INC (XXII) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of XXII, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of XXII, evaluating the profitability, health, valuation and growth aspects
- 22ND CENTURY GROUP INC (XXII) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- 22ND CENTURY GROUP INC (XXII) Sales and EPS estimates to see what analysts future expectations are.
- 22ND CENTURY GROUP INC (XXII) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- 22ND CENTURY GROUP INC (XXII) Insider and Institutional Ownership to learn about the owners and their transactions.
- 22ND CENTURY GROUP INC (XXII) Stock Chart to make your own analysis
- 22ND CENTURY GROUP INC (XXII) Latest news and press-releases to stay up to date.
Does 22ND CENTURY GROUP INC (XXII) stock pay dividends?
XXII does not pay a dividend.
When does 22ND CENTURY GROUP INC (XXII) report earnings?
22ND CENTURY GROUP INC (XXII) will report earnings on 2025-05-13.
What is the Price/Earnings (PE) ratio of 22ND CENTURY GROUP INC (XXII)?
22ND CENTURY GROUP INC (XXII) does not have a PE ratio as the earnings reported over the last twelve months were negative (-526.02).
What is the Short Interest ratio of 22ND CENTURY GROUP INC (XXII) stock?
The outstanding short interest for 22ND CENTURY GROUP INC (XXII) is 58.82% of its float. Check the ownership tab for more information on the XXII short interest.
XXII Technical Analysis
XXII Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to XXII. XXII may be in some trouble as it scores bad on both profitability and health.
XXII Financial Highlights
Over the last trailing twelve months XXII reported a non-GAAP Earnings per Share(EPS) of -526.02. The EPS increased by 96.8% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -117.51% | ||
| ROE | -634.77% | ||
| Debt/Equity | 1.29 |
XXII Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to XXII. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 89.2% and a revenue growth -15% for XXII